Financial statements Bioxon
Balance sheet of Bioxon
Company age:
Age:
10 y. 8 m. 9 d.
Share capital:
Share capital:
15 000 PLN
Balance sheet data of BIOXON
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 49 291,53 | 198 254,25 | 481 867,12 | 995 344,71 | 1 140 191,54 | 1 291 332,50 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 711 500,00 | 711 500,00 |
| B. Current assets | 49 291,53 | 198 254,25 | 481 867,12 | 995 344,71 | 428 691,54 | 579 832,50 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 49 291,53 | 198 254,25 | 481 867,12 | 995 344,71 | 1 140 191,54 | 1 291 332,50 |
| A. Equity | 8 094,69 | 17 715,88 | 90 094,05 | 138 017,43 | 199 930,21 | 348 362,73 |
| B. Liabilities and provisions for liabilities | 41 196,84 | 180 538,37 | 391 773,07 | 857 327,28 | 940 261,33 | 942 969,77 |
| I. Long-term liabilities | 0,00 | 5 000,00 | 5 000,00 | 0,00 | 17 929,13 | 0,00 |
| II. Short-term liabilities | 36 196,84 | 135 538,37 | 309 273,07 | 817 327,28 | 882 332,20 | 902 969,17 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.